États-Unis · Plateformes & données · MarketBeat

Biogen Q3 Earnings Call Highlights

Publié par MarketBeat · États-Unis il y a 59 min

Biogen (NASDAQ:BIIB) reported third-quarter 2026 revenue growth of 11% year over year, supported by its acquisition of Apellis and continued expansion of its growth-product…

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Biogen Q3 Earnings Call Highlights

À lire aussi

Silicon Motion Technology GAAP EPADS of $1.91 misses by $1.15, revenue of $560.2M beats by $31.1M

We stopped helping our neighbors with free home repairs and our friendship cooled. Who’s to blame?

Teladoc shares surge 9% on narrower-than-feared loss, raised outlook

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

UPS Stock In Focus As Wall Street Raises Price Targets – Truist Sees ‘Sustained Earnings Recovery’

Market News

Biogen Q3 Earnings Call Highlights

Partager

À lire aussi

Silicon Motion Technology GAAP EPADS of $1.91 misses by $1.15, revenue of $560.2M beats by $31.1M

We stopped helping our neighbors with free home repairs and our friendship cooled. Who’s to blame?

Teladoc shares surge 9% on narrower-than-feared loss, raised outlook

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

UPS Stock In Focus As Wall Street Raises Price Targets – Truist Sees ‘Sustained Earnings Recovery’

Market News